ImmunityBio Inc.
IBRX | NASDAQ
$8.87
+$0.42 (+4.97%)
Sep 22, 2026, 11:51 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.21 | -4.34 | -4.37 | -4.88 | -6.83 | -22.59 |
PEG Ratio | 0.15 | 0.09 | -0.41 | -0.29 | -0.13 | -0.56 |
PS Ratio | 16.08 | 121.07 | 4.11K | 8.45K | 2.53K | 8.44K |
PB Ratio | -3.65 | -3.65 | -4.35 | -4.53 | -9.77 | -42.63 |
P/FCF Ratio | -5.90 | -4.48 | -6.43 | -4.88 | -7.68 | -29.46 |
P/OCF Ratio | -5.97 | -4.56 | -6.96 | -6.01 | -8.62 | -29.74 |
OCF/S Ratio | -269.17 | -2.65K | -58.96K | -140.63K | -29.38K | -28.38K |
Debt / Equity Ratio | -1.76 | -1.03 | -1.24 | -1.62 | -2.67 | -2.30 |
Quick Ratio | 5.08 | 3.21 | 5.05 | 0.28 | 0.91 | 1.64 |
Current Ratio | 5.10 | 3.36 | 5.05 | 0.28 | 0.91 | 1.64 |
Asset Turnover | 0.23 | 0.04 | 0 | 0 | 0 | 0 |
Interest Coverage | -2.28 | -2.61 | -4.18 | -7.45 | -22.24 | -24.34 |
Return on Equity | 70.34% | 84.56% | 99.35% | 93.12% | 143.20% | 185.17% |
Return on Assets | -70.01% | -108% | -115.61% | -114.96% | -73.96% | -100.21% |
Return on Invested Capital | -56.95% | -102.60% | -80.24% | -118.66% | -82.13% | -138.43% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 99.34% | 100% | 100% | 100% | 100% | 100% |
Net Profit Margin | -310.18% | -2.8K% | -93.76K% | -173.57K% | -37.13K% | -36.67K% |
Pretax Profit Margin | -310.37% | -2.81K% | -93.87K% | -173.87K% | -37.46K% | -37.36K% |
Operating Profit Margin | -226% | -2.33K% | -58.24K% | -146.37K% | -35.36K% | -36.51K% |
FCF Margin | -272.56% | -2.7K% | -63.88K% | -173.2K% | -32.97K% | -28.66K% |
EBITDA Margin | -197.34% | -1.79K% | -76.96K% | -146.62K% | -34.34K% | -33.76K% |
Add to Watchlist
Select watchlists to add or remove IBRX